Sign inJoin waitlistJoin the waitlist

Reza Mehrazin

, Associate Professor · Icahn School of Medicine at Mount Sinai

Credentials: · · · ·

History

Icahn School of Medicine at Mount Sinai
Present
Icahn School of Medicine at Mount Sinai
Present

Temple University Hospital
Urology
University of Tennessee College of Medicine
2007–2012
University of Tennessee Health Science Center
2006–2007
Medical University of the Americas-Nevis
2002–2006

Research

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a…
Journal of Clinical Oncology · 2014 · 240 citations
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Nature Medicine · 2023 · 138 citations
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
Cancer Cell · 2022 · 119 citations

John Sfakianos
75 papers
Ithaar Derweesh
58 papers
Peter Wiklund
51 papers
RD
Reuben Ben David
39 papers · 39 as a resident
RA
Riccardo Autorino
38 papers
Hooman Djaladat
33 papers · 27 as a fellow
Chandru Sundaram
31 papers
Firas Abdollah
31 papers
Vitaly Margulis
31 papers
AG
Alireza Ghoreifi
29 papers · 29 as a resident
Mark Gonzalgo
28 papers
Soroush Rais-Bahrami
27 papers

Clinical trials

Use of Perioperative Pain Blocks In Urological Surgery
Principal investigator · Completed · Phase 3
Icahn School of Medicine at Mount Sinai
2019–2021